Evidence map›Paper›PMID 40366180›Full record

ArticleChemistry, an Asian journal2025

Sulfur-Mediated Ring-Opening Cyclization of Spirocyclopropanes for the Construction of Benzo[b]thiophene Skeleton.

Hisanori Nambu, Yuki Seto, Yuta Onuki, Koga Yamazaki, Keisuke Tomohara, Takayuki Yakura

Abstract read
In one paragraph

Article in Chemistry, an Asian journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hisanori NambuFaculty of Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, 930-0194, Japan.
Yuki SetoFaculty of Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, 930-0194, Japan.
Yuta OnukiFaculty of Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, 930-0194, Japan.
Koga YamazakiFaculty of Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, 930-0194, Japan.
Keisuke TomoharaLaboratory of Pharmaceutical Manufacturing Chemistry, Kyoto Pharmaceutical University, Kyoto, 607-8412, Japan.
Takayuki YakuraFaculty of Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama, 930-0194, Japan.

Funding

Hoansha Foundation
6 · The paper itself

Abstract

A novel approach for the construction of the benzo[b]thiophene skeleton has been developed. Regioselective ring-opening cyclization of cyclohexane-1,3-dione-2-spirocyclopropanes using sodium hydrosulfide as a sulfur-transfer reagent proceeded smoothly and subsequent addition of an acid afforded the corresponding tetrahydrobenzo[b]thiophen-4-one derivatives in good to excellent yields. Cycloheptane-1,3-dione-2-spirocyclopropanes could be also applied to the present protocol. In contrast, the reaction of monocyclic 1,1-diacetyl-2-phenylcyclopropane with sodium hydrosulfide and subsequent addition of an acid gave decomposition products instead of the desired product. This result suggests that the spiro structure is crucial for successful ring-opening cyclization. One of the products obtained from cyclohexane-1,3-dione-2-spirocyclopropanes could be converted into the 2-substituted 4-hydroxybenzo[b]thiophene derivative while avoiding oxidation of the sulfide to sulfoxide or sulfone. This protocol provides an alternative synthetic method to access benzo[b]thiophenes without using multisubstituted benzenes as starting materials, which are often difficult to prepare. To our knowledge, this is the first report of the synthesis of benzo[b]thiophenes from cyclopropanes.

Indexed as

CyclizationRegioselectivitySpirocyclopropanesSulfur heterocyclesSynthetic methods

Identifiers

PMID40366180
PMCPMC12392711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.